AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 294: L368-L377, 2008. First published December 14, 2007; doi:10.1152/ajplung.00036.2007
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/L368    most recent
00036.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moraes, T. J.
Right arrow Articles by Downey, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moraes, T. J.
Right arrow Articles by Downey, G. P.

Role of PAR2 in murine pulmonary pseudomonal infection

Theo J. Moraes,3,5 Raiza Martin,3 Jonathan D. Plumb,3 Eric Vachon,3 Cheryl M. Cameron,4 Ali Danesh,1 David J. Kelvin,1 Wolfram Ruf,5 and Gregory P. Downey2,3

1Department of Immunology and 2Division of Respirology, Department of Medicine, University of Toronto, 3Toronto General Hospital Research Institute of University Health Network, and 4Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada; and 5Department of Immunology, Scripps Research Institute, La Jolla, California

Submitted 23 January 2007 ; accepted in final form 7 December 2007

Proteinases can influence lung inflammation by various mechanisms, including via cleavage and activation of protease-activated receptors (PAR) such as PAR2. In addition, proteinases such as neutrophil and/or Pseudomonas-derived elastase can disarm PAR2 resulting in loss of PAR2 signaling. Currently, the role of PAR2 in host defense against bacterial infection is not known. Using a murine model of acute Pseudomonas aeruginosa pneumonia, we examined differences in the pulmonary inflammatory response between wild-type and PAR2–/– mice. Compared with wild-type mice, PAR2–/– mice displayed more severe lung inflammation and injury in response to P. aeruginosa infection as indicated by higher bronchoalveolar lavage fluid neutrophil numbers, protein concentration, and TNF-{alpha} levels. By contrast, IFN-{gamma} levels were markedly reduced in PAR2–/– compared with wild-type mice. Importantly, clearance of P. aeruginosa was diminished in PAR2–/– mice. In vitro testing revealed that PAR2–/– neutrophils killed significantly less bacteria than wild-type murine neutrophils. Further, both neutrophils and macrophages from PAR2–/– mice displayed significantly reduced phagocytic efficiency compared with wild-type phagocytes. Stimulation of PAR2 on macrophages using a PAR2-activating peptide resulted in enhanced phagocytosis directly implicating PAR2 signaling in the phagocytic process. We conclude that genetic deletion of PAR2 is associated with decreased clearance of P. aeruginosa. Our data suggest that a deficiency in IFN-{gamma} production and impaired bacterial phagocytosis are two potential mechanisms responsible for this defect.

neutrophil; phagocytosis; proteinase; innate immunity; bacterial killing; inflammation



Address for reprint requests and other correspondence: G. P. Downey, Academic Affairs, K701b, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206 (e-mail: downeyg{at}njc.org)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.